Abstract
Vasoactive intestinal peptide (VIP) is a 28 amino acid-residue neurovascular and gut peptide with a number of important biological activities. Recent in vitro studies suggest an immunomodulatory (depressant) role for VIP. In the present in vivo studies, employing the Hall and Morris sheep lymphocyte traffic model, acute infusions of VIP into cannulated afferent lymphatics of popliteal lymph nodes produced prompt and marked depressions in the output of both small recirculating and blast lymphocytes into popliteal efferent lymph, with a selective effect on T4 (CD4) lymphocytes. It has been suggested that the HIV (AIDS) virus may employ VIP or VIP-like receptors on brain cells and lymphocytes for intracellular access.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cutz E., Chan W., Track N. S., Goth A., Said S. I. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature. 1978 Oct 19;275(5681):661–662. doi: 10.1038/275661a0. [DOI] [PubMed] [Google Scholar]
- Guerrero J. M., Prieto J. C., Elorza F. L., Ramirez R., Goberna R. Interaction of vasoactive intestinal peptide with human blood mononuclear cells. Mol Cell Endocrinol. 1981 Feb;21(2):151–160. doi: 10.1016/0303-7207(81)90052-6. [DOI] [PubMed] [Google Scholar]
- HALL J. G., MORRIS B. The lymph-borne cells of the immune response. Q J Exp Physiol Cogn Med Sci. 1963 Jul;48:235–247. doi: 10.1113/expphysiol.1963.sp001660. [DOI] [PubMed] [Google Scholar]
- HALL J. G., MORRIS B. The output of cells in lymph from the popliteal node of sheep. Q J Exp Physiol Cogn Med Sci. 1962 Oct;47:360–369. doi: 10.1113/expphysiol.1962.sp001620. [DOI] [PubMed] [Google Scholar]
- Moore T. C., Khan F. Lymphocyte traffic effects of systemic and local lidocaine in sheep. J Surg Res. 1986 Sep;41(3):279–285. doi: 10.1016/0022-4804(86)90037-5. [DOI] [PubMed] [Google Scholar]
- Moore T. C., Lachmann P. J. Cyclic AMP reduces and cyclic GMP increases the traffic of lymphocytes through peripheral lymph nodes of sheep in vivo. Immunology. 1982 Nov;47(3):423–428. [PMC free article] [PubMed] [Google Scholar]
- Moore T. C. Modification of lymphocyte traffic by vasoactive neurotransmitter substances. Immunology. 1984 Jul;52(3):511–518. [PMC free article] [PubMed] [Google Scholar]
- Moore T. C. The modulation by prostaglandins of increases in lymphocyte traffic induced by bradykinin. Immunology. 1984 Mar;51(3):455–460. [PMC free article] [PubMed] [Google Scholar]
- Ottaway C. A., Greenberg G. R. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. J Immunol. 1984 Jan;132(1):417–423. [PubMed] [Google Scholar]
- Ottaway C. A. In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. J Exp Med. 1984 Oct 1;160(4):1054–1069. doi: 10.1084/jem.160.4.1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pert C. B., Hill J. M., Ruff M. R., Berman R. M., Robey W. G., Arthur L. O., Ruscetti F. W., Farrar W. L. Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9254–9258. doi: 10.1073/pnas.83.23.9254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Said S. I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 1970 Sep 18;169(3951):1217–1218. doi: 10.1126/science.169.3951.1217. [DOI] [PubMed] [Google Scholar]
- Said S. I., Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature. 1970 Feb 28;225(5235):863–864. doi: 10.1038/225863a0. [DOI] [PubMed] [Google Scholar]